Categories
- All
- Animal & Veterinary
- Award
- Biologics
- Coronavirus
- Cosmetics
- Design
- Dietary Supplements
- Drugs
- Follow @FDAmedia on Twitter
- Follow @FDAMedia on X
- Follow @US_FDA on Twitter
- Follow @US_FDA on X
- Follow FDA on Facebook
- Food & Beverages
- Healthy
- Hotel
- Infant Formula & Foods
- Infectious Disease
- Lifestyle
- Medical Devices
- Nature
- Office
- Over-the-Counter Drugs
- Tobacco
- Training
- Travel Tips
- Travel Tips
- Vaccines
Filter Articles
Search by title or filter by category
911 articles found
-
FDA Roundup: July 23, 2024Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA approved Femlyv (norethindrone acetate and ethinyl estradiol), the... -
FDA, FTC Continue Joint Effort to Protect Consumers Against Companies Illegally Selling Copycat Delta-8 THC Food ProductsToday, the U.S. Food and Drug Administration and the Federal Trade Commission (FTC) issued warning letters to five companies for illegally selling copycat food products containing delta-8 THC and intr...
-
FDA Roundup: July 12, 2024Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Wednesday, the FDA issued a Letter to Health Care Providers to notify providers th...
-
FDA Updates Guidance to Further Empower Companies to Address the Spread of MisinformationToday, the U.S. Food and Drug Administration is advancing its mission of ensuring the public has access to accurate, up-to-date science-based information to inform decisions about FDA-regulated medica...
-
FDA Roundup: July 5, 2024Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Wednesday, the FDA updated the advisory for the investigation of Salmonella illnesse...
-
FDA Roundup: July 2, 2024Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA approved Kisunla (donanemab-azbt) injection for the treatment of Alzheim...
-
FDA Roundup: June 28, 2024Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA updated the advisory for illnesses associated with eating Diamond Shruumz...
-
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA TestToday, the U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert Xpress System, the first hepatitis C virus (HCV) test that can be used to b...
-
FDA Guidance Provides New Details on Diversity Action Plans Required for Certain Clinical StudiesToday, the U.S. Food and Drug Administration issued a draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies,” to assist me...
-
FDA Roundup: June 25, 2024Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA issued a Small Entity Compliance Guide to assist small entities in c...